Structure (Pyrazinamide Structure)
Pyrazinamide Tablet
Product Images NDC 70954-484
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pyrazinamide (NDC 70954-484). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Container-100 (Container 100 Counts)
NDC 70954-484-30 is a medication that comes in the form of 100 tablets. Each tablet contains Pyrazinamide USP of 500 mg. The recommended adult dosage is 15-30 mg/kg once daily not exceeding 2g. It is advisable to consult the package literature for more information. The tablets should be dispensed in a light-resistant container that has a child-resistant closure. The medication should be stored at a controlled room temperature of 20°C to 25°C. Novitium Pharma, LLC located in New Jersey manufactures this medication. Keep this medication out of the reach of children. This information was last issued in January 2021.*
Container-500 (Container 500 Counts)
This is a description of a medication with the NDC code 70954-484-40. It contains 500 tablets and each tablet contains Pyrazinamide, USP 500 mg. The usual adult dosage is mentioned as 15-30 mg/kg once daily, not to exceed 2 g. The manufacturer is Novitium Pharma LLC in East Windsor, New Jersey. The medication should be stored at a controlled room temperature and kept out of the reach of children. The text also mentions that the medication is available only with a prescription.*
Container-60 (Container 60 Counts)
NDC 70954-484-10 is a bottle of Pyrazinamide Tablets, USP manufactured by Novitium Pharma LLC. Each bottle contains 60 tablets and each tablet contains 500 mg of Pyrazinamide. It is typically taken at a dosage of 15-30 mg/kg once daily, not to exceed 2 g. The package literature should be consulted for complete information. The tablets should be dispensed in a tight, light-resistant container that has a child-resistant closure. The medication should be stored at 20° to 25°C (68° to 77°F) and kept out of reach of children. The product was last issued in January 2021.*
Container-90 (Container 90 Counts)
NDC 70954-484-20 is a bottle of 90 tablets of Pyrazinamide, each containing 500mg of the active ingredient. Pyrazinamide is a medication used in the treatment of tuberculosis. The usual adult dosage is 15-30mg/kg once daily, not to exceed 2g. This medication should be kept out of the reach of children and stored in a tight, light-resistant container at 20° to 25°C (68° to 77°F). It is manufactured by Novitium Pharma, LLC in East Windsor, New Jersey. The complete information can be found in the package literature.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
